The effect of combination therapy with rituximab and intravenous immunoglobulin on the progression of chronic antibody mediated rejection in renal transplant recipients. [electronic resource]
- Journal of immunology research 2014
- 828732 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2314-7156
10.1155/2014/828732 doi
Adult Antibodies--blood Antibodies, Monoclonal, Murine-Derived--therapeutic use Chronic Disease Disease Progression Drug Administration Schedule Drug Therapy, Combination Female Glomerular Filtration Rate Graft Rejection--blood Humans Immunoglobulins, Intravenous--therapeutic use Immunologic Factors--therapeutic use Kidney Transplantation Male Middle Aged Renal Insufficiency, Chronic--immunology Rituximab Treatment Outcome